BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gu XQ, Zheng WP, Teng DH, Sun JS, Zheng H. Impact of non-oncological factors on tumor recurrence after liver transplantation in hepatocellular carcinoma patients. World J Gastroenterol 2016; 22(9): 2749-2759 [PMID: 26973413 DOI: 10.3748/wjg.v22.i9.2749] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhu Y, Gu L, Chen T, Zheng G, Ye C, Jia W. Factors influencing early recurrence of hepatocellular carcinoma after curative resection. J Int Med Res 2020;48:300060520945552. [PMID: 33106072 DOI: 10.1177/0300060520945552] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Kornberg A, Witt U, Schernhammer M, Kornberg J, Müller K, Friess H, Thrum K. The role of preoperative albumin‐bilirubin grade for oncological risk stratification in liver transplant patients with hepatocellular carcinoma. J Surg Oncol 2019;120:1126-36. [DOI: 10.1002/jso.25721] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
3 Albekairy AM, Abdel-Razaq WS, Alkatheri AM, Debasi TMA, Otaibi NEA, Qandil AM. The impact of immunosuppressant therapy on the recurrence of hepatitis C post-liver transplantation. Int J Health Sci (Qassim) 2018;12:78-87. [PMID: 30022908] [Reference Citation Analysis]
4 Fu XT, Shi YH, Zhou J, Peng YF, Liu WR, Shi GM, Gao Q, Wang XY, Song K, Fan J, Ding ZB. Association of hepatitis status with surgical outcomes in patients with dual hepatitis B and C related hepatocellular carcinoma. Infect Agent Cancer 2017;12:28. [PMID: 28559922 DOI: 10.1186/s13027-017-0137-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
5 Bina Possatto M, de Ataíde E, Fazzio Escanhoela C, Sevá-pereira T, de Cassia Martins Alves da Silva R, Felicio H, de Navarro Amado L, Ferreira da Silva R, Soares Lima A, Boin I. Factors Related to Hepatocellular Carcinoma Recurrence After Liver Transplantation—A Brazilian Multicenter Study. Transplantation Proceedings 2017;49:863-6. [DOI: 10.1016/j.transproceed.2017.01.055] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
6 Sapisochin G, Bruix J. Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches. Nat Rev Gastroenterol Hepatol 2017;14:203-17. [PMID: 28053342 DOI: 10.1038/nrgastro.2016.193] [Cited by in Crossref: 221] [Cited by in F6Publishing: 211] [Article Influence: 36.8] [Reference Citation Analysis]
7 Kakodkar R. Inappropriate inferences from registry data: Pitfalls of inaccurate data handling? Indian J Gastroenterol 2017;36:77-80. [PMID: 28357774 DOI: 10.1007/s12664-017-0749-1] [Reference Citation Analysis]
8 Liu L, Ji P, Qu N, Pu WL, Jiang DW, Liu WY, Li YQ, Shi RL. The impact of high co-expression of Sp1 and HIF1α on prognosis of patients with hepatocellular cancer. Oncol Lett 2016;12:504-12. [PMID: 27347172 DOI: 10.3892/ol.2016.4634] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]